Cdtx on stockwits
WebAPDN Stock 12 Months Forecast. $4.00. (253.98% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Applied DNA Sciences in the last 3 months. The average price target is $4.00 with a high forecast of $5.00 and a low forecast of $3.00. The average price target represents a 253.98% change from the last price of $1.13. WebApr 14, 2024 · Cidara Therapeutics Inc. (NASDAQ:CDTX) shares, rose in value on Thursday, 04/13/23, with the stock price up by 4.59% to the previous day’s close as …
Cdtx on stockwits
Did you know?
WebPROFILE ( CDTX) Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of novel anti-infectives. Its product … WebAnalyst Consensus Strong Buy Average Price Target: $4.83 ( 154.21% Upside) Blogger Sentiment Bullish CDTX Sentiment 100% Sector Average 69% Insider Transactions Sold Shares Worth $25.7K over the Last 3 Months Crowd Wisdom Very Positive Last 7 Days 0.6% Last 30 Days 13.2% News Sentiment Neutral Bullish news 50% Bearish news 50% …
WebBased on analysts offering 12 month price targets for CDTX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. WebMar 28, 2024 · Get instant access to professional analysis, market sentiment, trending stocks, trading ideas, new market trends and more. FEATURES: TAP INTO THE GLOBAL VOICE OF FINANCE AND INVESTING Discuss the...
WebCDTX Growth Metrics. The year over year net income to common stockholders growth rate now stands at 41.54%. Its 2 year cash and equivalents growth rate is now at -48.91%. Its … WebApr 16, 2015 · Get a Leaderboard Chart for CDTX? See How IBD Rates . CDTX. Daily Weekly. Cidara Therapeutics Inc (CDTX) - DEVELOPS NOVEL ANTI-INFECTIVES FOR THE TREATMENT OF SERIOUS FUNGAL INFECTIONS. GROUP LEADERSHIP. Medical-Biomed/Biotech Group. CDTX. is not ranked # N/A. in group. CPRX. is ranked # 1. 1 st in …
Web30.57%. Trailing 12-Months. The Cidara Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst …
WebApr 10, 2024 · 2 Wall Street analysts have issued 1-year price objectives for Cidara Therapeutics' shares. Their CDTX share price forecasts range from $5.00 to $6.00. On … gilead returns policyWebApr 11, 2024 · Onconova Therapeutics - ONTX Stock Forecast, Price & News $0.72 +0.00 (+0.39%) (As of 03/23/2024 03:59 PM ET) Compare Today's Range $0.70 $0.77 50-Day Range $0.69 $1.42 52-Week Range $0.62 $2.04 Volume 83,617 shs Average Volume 236,609 shs Market Capitalization $15.11 million P/E Ratio N/A Dividend Yield N/A Price … gilead rd huntersville ncWebApr 10, 2024 · A high-level overview of Cidara Therapeutics, Inc. (CDTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. gilead ridge townhomes for saleWebBJDX Stock Price - Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable gilead scholar rockWebDecibel Therapeutics, Inc. discovers and develops medicines to protect, repair, and restore hearing. The firm focuses on hearing disorders, including noise-induced hearing loss, residual hearing preservation or improved sound fidelity with cochlear implants, presbycusis or age-related hearing loss, tinnitus, a persistent ringing in the ears, and … gilead remdesivir studyWebMar 22, 2024 · Cidara Therapeutics Announces Pricing of Public Offerings of Common Stock and Preferred Stock. Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious diseases, today announced the pricing of concurrent but … ft tv duddy plaing huggy wuggyWebCidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of novel anti-infectives. Its product pipeline includes … gilead quarterly earnings